Passive Immunization with mAbs Against Aerosolized Ricin Toxin
The Centers for Disease Control and Prevention (CDC) recognize that the deliberate release of biological toxins and highly infectious agents ...
Tag: Ricin
Belarus Man Indicted for Mailing Ricin and Threats to Pelican Bay State Prison
A federal grand jury in San Francisco indicted Vladislav Victorvic Timoshchuk with attempted transfer of a toxin for use as ...
FDA Grants Soligenix “Fast Track” Designation for RiVax® in the Prevention of Ricin Poisoning
Soligenix, Inc. announced on Feb. 13 that its RiVax® (heat stable ricin toxin vaccine) development program for prevention of ricin intoxication ...
Biological Terrorism in Indonesia
In mid-October 2019, the Indonesian police discovered that a cell of Jamaah Ansharud Daulah (JAD) – the largest pro-Islamic State (IS) network ...
Soligenix Receives European and Canadian Patents for Ricin Toxin Vaccine
Soligenix, Inc. announced on July 9 that it has received notice of allowance for European and Canadian patent applications further ...
Anti-Ricin Monoclonal Antibody Licensed for Development
AntoXa Corporation has obtained a license from Defence Research & Development Canada (DRDC), an Agency of the Canadian Department of ...
Soligenix Receives Japanese Patent for Vaccine Heat Stabilization Technology
Soligenix, Inc. announced today that it has been granted a Japanese patent (number 6110845) further extending protection around ThermoVax including ...
Soligenix Advances Ricin Vaccine Collaboration with IDT Biologika
Soligenix, Inc. announced today that it has extended its collaboration with IDT Biologika for the manufacture of RiVax, the company’s ...
Ricin Vaccine Featured at Rare Diseases and Orphan Products Summit
Credit: Shutterstock Soligenix, Inc. will present preclinical efficacy findings from its RiVax™ ricin toxin vaccine program ...
FDA Contract Supports Ricin Detection in Food Samples
The Food and Drug Administration has announced intentions to issue a sole-source award to Base Pair Biotechnologies to continue development ...
Battelle Fills Central Role in Military’s Medical Countermeasure Enterprise
The U.S. Army's Joint Program Executive Office for Chemical and Biological Defense (JPEO-CBD) has again chosen Battelle to perform critical medical ...
Soligenix Wins Additional 4.3M to Advance Ricin Vaccine Manufacturing
Soligenix, Inc. today announced that the National Institute of Allergy and Infectious Diseases (NIAID) has exercised an option for RiVax™ ...
How the FBI Stopped a Murder by Ricin Poisoning
The shipment sent by the FBI to Cheng Le contained, among other things, a pill bottle ...
DoD Medical Countermeasure Systems Broad Agency Announcement
A Broad Agency Announcement (BAA) for the U.S. military’s Chemical Biological Radiological and Nuclear (CBRN) medical countermeasure efforts was renewed ...
Federal Perspective on the State of Our Nation’s Biodefense
The following contains the written testimony of OHA National Bio-surveillance Integration Center Acting Director Dr. Aaron Firoved for a Senate ...
Thermostable Ricin Vaccine Gets Another Funding Boost
Soligenix, Inc. is getting new funds from the National Institute of Allergy and Infectious Diseases (NIAID) to support advanced development ...
ECBC’s Biothreat Detection Self-Test Kit for Soldiers
The Edgewood Chemical Biological Center’s (ECBC) newly developed biological self-test kit can quickly tell soldiers on the ground whether they’ve ...
Pharma Leaders Issue Joint Declaration on Combating Antimicrobial Resistance
More than 90 leading international pharmaceutical, generics, diagnostics and biotechnology companies, as well as key industry bodies, have come together ...
DoD CBRN Medical Countermeasure Consortium
Military program managers briefed biopharmaceutical industry and research organization representatives during a Nov. 2 Industry Day, part of an initiative ...
NIAID Exercises Option on Thermostable Ricin Vaccine Contract
Soligenix, Inc. today announced that the National Institute of Allergy and Infectious Diseases (NIAID) has exercised its option to advance ...
